Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial by Grothey, Axel, MD, Cutsem, Eric Van, Prof, Sobrero, Alberto, MD, Siena, Salvatore, MD, Falcone, Alfredo, MD, Ychou, Marc, MD, Humblet, Yves, MD, Bouché, Olivier, MD, Mineur, Laurent, MD, Barone, Carlo, MD, Adenis, Antoine, MD, Tabernero, Josep, MD, Yoshino, Takayuki, MD, Lenz, Heinz-Josef, MD, Goldberg, Richard M, MD, Sargent, Daniel J, PhD, Cihon, Frank, MS, Cupit, Lisa, MD, Wagner, Andrea, MD, Laurent, Dirk, DrMed

Get full text

Randomized phase III trial of regorafenib in metastatic colorectal cancer: analysis of the CORRECT Japanese and non-Japanese subpopulations by Yoshino, Takayuki, Komatsu, Yoshito, Yamada, Yasuhide, Yamazaki, Kentaro, Tsuji, Akihito, Ura, Takashi, Grothey, Axel, Van Cutsem, Eric, Wagner, Andrea, Cihon, Frank, Hamada, Yoko, Ohtsu, Atsushi

Get full text

Lack of effect of ketoconazole-mediated CYP3A inhibition on sorafenib clinical pharmacokinetics by LATHIA, Chetan, LETTIERI, John, CIHON, Frank, GALLENTINE, Martha, RADTKE, Martin, SUNDARESAN, Pavur

Get full text

Phase I Trial of BAY 50-4798, an Interleukin-2–Specific Agonist in Advanced Melanoma and Renal Cancer by Margolin, Kim, Atkins, Michael B, Dutcher, Janice P, Ernstoff, Marc S, Smith, 2nd, John W, Clark, Joseph I, Baar, Joseph, Sosman, Jeffrey, Weber, Jeffrey, Lathia, Chetan, Brunetti, Janice, Cihon, Frank, Schwartz, Brian

Get full text

Sorafenib for Older Patients With Renal Cell Carcinoma: Subset Analysis From a Randomized Trial by Eisen, Tim, Oudard, Stéphane, Szczylik, Cezary, Gravis, Gwenaelle, Heinzer, Hans, Middleton, Richard, Cihon, Frank, Anderson, Sibyl, Shah, Sonalee, Bukowski, Ronald, Escudier, Bernard

Get full text

A phase I open-label study evaluating the cardiovascular safety of sorafenib in patients with advanced cancer by Tolcher, Anthony W., Appleman, Leonard J., Shapiro, Geoffrey I., Mita, Alain C., Cihon, Frank, Mazzu, Arthur, Sundaresan, Pavur R.

Get full text

Simultaneous administration of vardenafil and tamsulosin does not induce clinically significant hypotension in patients with benign prostatic hyperplasia by Auerbach, Stephen M., Gittelman, Marc, Mazzu, Arthur, Cihon, Frank, Sundaresan, Pavur, White, William B.

Get full text

Phase I trial of BAY 50-4798, an lnterleukin -2 -specific agonist in advanced melanoma and renal cancer by MARGOLIN, Kim, ATKINS, Michael B, BRUNETTI, Janice, CIHON, Frank, SCHWARTZ, Brian, DUTCHER, Janice P, ERNSTOFF, Marc S, SMITH, John W, CLARK, Joseph I, BAAR, Joseph, SOSMAN, Jeffrey, WEBER, Jeffrey, LATHIA, Chetan

Get full text

Simultaneous administration of vardenafil and tamsulosin does not induce clinically significant hypotension in patients with benign prostatic hyperplasia. Commentary by AUERBACH, Stephen M, GITTELMAN, Marc, MAZZU, Arthur, CIHON, Frank, SUNDARESAN, Pavur, WHITE, William B, TE, Alexis E

Get full text

Differential effects of simvastatin and atorvastatin on high‐density lipoprotein cholesterol and apolipoprotein A‐I are consistent across hypercholesterolemic patient subgroups by Davidson, Michael H., Ose, Leiv, Frohlich, Jiri, Scott, Russell S., Dujovne, Carlos A., Escobar, Ivan D., Bertolami, Marcelo C., Cihon, Frank, MacCubbin, Darbie L., Mercuri, Michele

Get full text